Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain. Ketamine, astrocytic inhibitor and pain

Molecular Pain

Volumn 6, Issue , 2010, Pages

  Mei, Xiao Peng ^a   Wang, Wei ^a   Wang, Wen ^a   Zhu, Chao ^a   Chen, Lei ^a   Zhang, Ting ^a   Xu, Li Xian ^a   Wu, Sheng Xi ^a   Li, Yun Qing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOADIPIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ANALGESIC AGENT;

ALLODYNIA; ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG POTENTIATION; MALE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; ROTAROD TEST; TREATMENT OUTCOME; ANIMAL; ASTROCYTE; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; HYPERALGESIA; INTRASPINAL DRUG ADMINISTRATION; LIGATION; METABOLISM; MOTOR ACTIVITY; NEURALGIA; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; SPINAL NERVE; SPRAGUE DAWLEY RAT;

2-AMINOADIPIC ACID; ANALGESICS; ANIMALS; ASTROCYTES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HYPERALGESIA; INJECTIONS, SPINAL; KETAMINE; LIGATION; MALE; MOTOR ACTIVITY; NEURALGIA; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; ROTAROD PERFORMANCE TEST; SPINAL NERVES;

EID: 77956486990     PISSN: 17448069     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8069-6-50     Document Type: Article

References (51)

1. Fields RD, Stevens-Graham B. New insights into neuron-glia communication. Science 2002, 298:556-562. 10.1126/science.298.5593.556, 1226318, 12386325.
2. Xiao WH, Bennett GJ. Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine. Pain 2008, 135:262-270. 10.1016/j.pain.2007.06.001, 2689385, 17659836.
3. Xing GG, Liu FY, Qu XX, Han JS, Wan Y. Long-term synaptic plasticity in the spinal dorsal horn and its modulation by electroacupuncture in rats with neuropathic pain. Exp Neurol 2007, 208:323-332.
4. Kozek SA, Sator-Katzenschlager S, Kress HG. Intrathecal S(+)-ketamine in refractory neuropathic cancer pain. Pain 2006, 121:283-284. 10.1016/j.pain.2006.01.007, 16513276.
5. Kiefer RT, Rohr P, Ploppa A, Dieterich HJ, Grothusen J, Koffler S, Altemeyer KH, Unertl K, Schwartzman RJ. Efficacy of Ketamine in Anesthetic Dosage for the Treatment of Refractory Complex Regional Pain Syndrome: An Open-Label Phase II Study. Pain Med 2008, 9:1173-1201. 10.1111/j.1526-4637.2007.00402.x, 18266808.
6. Vranken JH, Troost D, Wegener JT, Kruis MR, van der Vegt MH. Neuropathological findings after continuous intrathecal administration of S(+)-ketamine for the management of neuropathic cancer pain. Pain 2005, 117:231-235. 10.1016/j.pain.2005.06.014, 16098665.
7. Cvrcek P. Side effects of ketamine in the long-term treatment of neuropathic pain. Pain Med 2008, 9:253-257. 10.1111/j.1526-4637.2007.00314.x, 18298710.
8. Alvarez P, Saavedra G, Hernandez A, Paeile C, Pelissier T. Synergistic antinociceptive effects of ketamine and morphine in the orofacial capsaicin test in the rat. Anesthesiology 2003, 99:969-975. 10.1097/00000542-200310000-00033, 14508333.
9. Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain 2005, 6:644-649. 10.1016/j.jpain.2005.04.008, 16202956.
10. Huang C, Li HT, Shi YS, Han JS, Wan Y. Ketamine potentiates the effect of electroacupuncture on mechanical allodynia in a rat model of neuropathic pain. Neurosci Lett 2004, 368:327-331. 10.1016/j.neulet.2004.07.073, 15364421.
11. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021. 10.1038/nature04223, 16355225.
12. Guo W, Wang H, Watanabe M, Shimizu K, Zou S, LaGraize SC, Wei F, Dubner R, Ren K. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 2007, 27:6006-6018. 10.1523/JNEUROSCI.0176-07.2007, 2676443, 17537972.
13. Watkins LR, Martin D, Ulrich P, Tracey KJ, Maier SF. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 1997, 71:225-235. 10.1016/S0304-3959(97)03369-1, 9231865.
14. Meunier A, Mauborgne A, Masson J, Mallet J, Pohl M. Lentiviral-mediated targeted transgene expression in dorsal spinal cord glia: tool for the study of glial cell implication in mechanisms underlying chronic pain development. J Neurosci Methods 2008, 167:148-159. 10.1016/j.jneumeth.2007.07.022, 17949823.
15. Meunier A, Latremoliere A, Dominguez E, Mauborgne A, Philippe S, Hamon M, Mallet J, Benoliel JJ, Pohl M. Lentiviral-mediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat. Mol Ther 2007, 15:687-697.
16. Garry EM, Delaney A, Blackburn-Munro G, Dickinson T, Moss A, Nakalembe I, Robertson DC, Rosie R, Robberecht P, Mitchell R, Fleetwood-Walker SM. Activation of p38 and p42/44 MAP kinase in neuropathic pain: involvement of VPAC2 and NK2 receptors and mediation by spinal glia. Mol Cell Neurosci 2005, 30:523-537. 10.1016/j.mcn.2005.08.016, 16202621.
17. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S, Tracey K, Martin D, Maier SF, Watkins LR. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 2003, 23:1026-1040.
18. Watkins LR, Milligan ED, Maier SF. Spinal cord glia: new players in pain. Pain 2001, 93:201-205. 10.1016/S0304-3959(01)00359-1, 11514078.
19. Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 2005, 28:101-107. 10.1016/j.tins.2004.12.002, 15667933.
20. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007, 10:1361-1368. 10.1038/nn1992, 17965656.
21. Zhuang ZY, Wen YR, Zhang DR, Borsello T, Bonny C, Strichartz GR, Decosterd I, Ji RR. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 2006, 26:3551-3560. 10.1523/JNEUROSCI.5290-05.2006, 16571763.
22. Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 2003, 306:624-630. 10.1124/jpet.103.052407, 12734393.
23. Zhuang ZY, Gerner P, Woolf CJ, Ji RR. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005, 114:149-159. 10.1016/j.pain.2004.12.022, 15733640.
24. Ikeda H, Tsuda M, Inoue K, Murase K. Long-term potentiation of neuronal excitation by neuron-glia interactions in the rat spinal dorsal horn. Eur J Neurosci 2007, 25:1297-1306. 10.1111/j.1460-9568.2007.05386.x, 17425556.
25. Wang W, Wang Y, Huang J, Wu S, Li YQ. Temporal changes of astrocyte activation and glutamate transporter-1 expression in the spinal cord after spinal nerve ligation-induced neuropathic pain. Anat Rec (Hoboken) 2008, 291:513-518.
26. Garraway SM, Xu Q, Inturrisi CE. Design and evaluation of small interfering RNAs that target expression of the N-methyl-D-aspartate receptor NR1 subunit gene in the spinal cord dorsal horn. J Pharmacol Exp Ther 2007, 322:982-988. 10.1124/jpet.107.123125, 17551091.
27. Wilson JA, Nimmo AF, Fleetwood-Walker SM, Colvin LA. A randomised double blind trial of the effect of pre-emptive epidural ketamine on persistent pain after lower limb amputation. Pain 2008, 135:108-118. 10.1016/j.pain.2007.05.011, 17583431.
28. Gao X, Kim HK, Chung JM, Chung K. Enhancement of NMDA receptor phosphorylation of the spinal dorsal horn and nucleus gracilis neurons in neuropathic rats. Pain 2005, 116:62-72. 10.1016/j.pain.2005.03.045, 15936881.
29. Xu DD, Mo ZX, Yung KK, Yang Y, Leung AW. Individual and combined effects of methamphetamine and ketamine on conditioned place preference and NR1 receptor phosphorylation in rats. Neurosignals 2006, 15:322-331. 10.1159/000127492, 18437031.
30. Petrenko AB, Yamakura T, Fujiwara N, Askalany AR, Baba H, Sakimura K. Reduced sensitivity to ketamine and pentobarbital in mice lacking the N-methyl-D-aspartate receptor GluRepsilon1 subunit. Anesth Analg 2004, 99:1136-1140. table of contents, 10.1213/01.ANE.0000131729.54986.30, 15385364.
31. Kudoh A, Kudoh E, Katagai H, Takazawa T. Ketamine suppresses norepinephrine-induced inositol 1,4,5-trisphosphate formation via pathways involving protein kinase C. Anesth Analg 2002, 94:552-557. table of contents, 10.1097/00000539-200203000-00013, 11867373.
32. Lu HW, He GN, Ma H, Wang JK. Ketamine reduces inducible superoxide generation in human neutrophils in vitro by modulating the p38 mitogen-activated protein kinase (MAPK)-mediated pathway. Clin Exp Immunol 2010, 160:450-456. 10.1111/j.1365-2249.2010.04111.x, 20345980.
33. Zou X, Lin Q, Willis WD. Effect of protein kinase C blockade on phosphorylation of NR1 in dorsal horn and spinothalamic tract cells caused by intradermal capsaicin injection in rats. Brain Res 2004, 1020:95-105. 10.1016/j.brainres.2004.06.017, 15312791.
34. Jin SX, Zhuang ZY, Woolf CJ, Ji RR. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 2003, 23:4017-4022.
35. Katsura H, Obata K, Miyoshi K, Kondo T, Yamanaka H, Kobayashi K, Dai Y, Fukuoka T, Sakagami M, Noguchi K. Transforming growth factor-activated kinase 1 induced in spinal astrocytes contributes to mechanical hypersensitivity after nerve injury. Glia 2008, 56:723-733. 10.1002/glia.20648, 18293403.
36. Khurgel M, Koo AC, Ivy GO. Selective ablation of astrocytes by intracerebral injections of alpha-aminoadipate. Glia 1996, 16:351-358. 10.1002/(SICI)1098-1136(199604)16:4<351::AID-GLIA7>3.0.CO;2-2, 8721675.
37. Mei X, Wang W, Wang W, Li Y, Zhang H, Wu S, Li Y, Xu L. Inhibiting astrocytic activation: a novel analgesic mechanism of ketamine at the spinal level?. J Neurochem 2009, 109:1691-1700. 10.1111/j.1471-4159.2009.06087.x, 19383087.
38. Kosson D, Klinowiecka A, Kosson P, Bonney I, Carr DB, Mayzner-Zawadzka E, Lipkowski AW. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin. Eur J Pain 2008, 12:611-616. 10.1016/j.ejpain.2007.10.005, 18068383.
39. Kollender Y, Bickels J, Stocki D, Maruoani N, Chazan S, Nirkin A, Meller I, Weinbroum AA. Subanaesthetic ketamine spares postoperative morphine and controls pain better than standard morphine does alone in orthopaedic-oncological patients. Eur J Cancer 2008, 44:954-962. 10.1016/j.ejca.2008.02.021, 18396035.
40. Cao L, Tanga FY, Deleo JA. The contributing role of CD14 in toll-like receptor 4 dependent neuropathic pain. Neuroscience 2009, 158:896-903. 10.1016/j.neuroscience.2008.10.004, 2701510, 18976692.
41. Bettoni I, Comelli F, Rossini C, Granucci F, Giagnoni G, Peri F, Costa B. Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 2008, 56:1312-1319. 10.1002/glia.20699, 18615568.
42. Obata K, Katsura H, Miyoshi K, Kondo T, Yamanaka H, Kobayashi K, Dai Y, Fukuoka T, Akira S, Noguchi K. Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. J Neurochem 2008, 105:2249-2259. 10.1111/j.1471-4159.2008.05353.x, 18363823.
43. Brahmachari S, Fung YK, Pahan K. Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J Neurosci 2006, 26:4930-4939. 10.1523/JNEUROSCI.5480-05.2006, 1963412, 16672668.
44. Parri R, Crunelli V. Astrocytes target presynaptic NMDA receptors to give synapses a boost. Nat Neurosci 2007, 10:271-273. 10.1038/nn0307-271, 17318217.
45. Jourdain P, Bergersen LH, Bhaukaurally K, Bezzi P, Santello M, Domercq M, Matute C, Tonello F, Gundersen V, Volterra A. Glutamate exocytosis from astrocytes controls synaptic strength. Nat Neurosci 2007, 10:331-339. 10.1038/nn1849, 17310248.
46. Slezak M, Pfrieger FW. New roles for astrocytes: regulation of CNS synaptogenesis. Trends Neurosci 2003, 26:531-535. 10.1016/j.tins.2003.08.005, 14522145.
47. Wirkner K, Gunther A, Weber M, Guzman SJ, Krause T, Fuchs J, Koles L, Norenberg W, Illes P. Modulation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex by P2Y receptor activation. Cereb Cortex 2007, 17:621-631. 10.1093/cercor/bhk012, 16648456.
48. Zhang RX, Li A, Liu B, Wang L, Ren K, Zhang H, Berman BM, Lao L. IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain 2008, 135:232-239. 10.1016/j.pain.2007.05.023, 2323207, 17689191.
49. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110. 10.1016/0304-3959(83)90201-4, 6877845.
50. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50:355-363. 10.1016/0304-3959(92)90041-9, 1333581.
51. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63. 10.1016/0165-0270(94)90144-9, 7990513.